Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Astrazeneca Pharma India LtdIndustry : Pharmaceuticals - Multinational
BSE Code:506820 NSE Symbol: ASTRAZEN P/E (TTM) :83.39
ISIN Demat:INE203A01020 Div & Yield %:0.3 EPS (TTM) :63.8
Book Value (RS) :261.98604 Market Cap (Rs Cr.):13301 Face Value (RS) :2
    Change Company 
YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.010.020.030.020.00
Long Term Debt-Equity Ratio0.010.010.020.010.00
Current Ratio2.202.121.881.681.67
Fixed Assets5.774.905.566.586.45
Inventory6.075.375.015.876.30
Debtors10.379.429.6610.2110.84
Interest Cover Ratio273.7688.41117.60100.970.00
PBIDTM (%)18.8212.5318.2316.0712.03
PBITM (%)17.2010.4315.7613.849.98
PBDTM (%)18.7512.4118.1015.9412.03
CPM (%)14.219.7513.9410.919.53
APATM (%)12.597.6511.478.687.48
ROCE (%)30.4716.7629.9433.6326.12
RONW (%)22.9512.7322.7421.7119.88

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)